Skip to main content
. 2020 Jan 16;30(2):146–162. doi: 10.1038/s41422-019-0263-3

Table 1.

Reagents and resources.

REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Vinculin Sigma-Aldrich Cat#V4505
SLC7A11/xCT (D2M7A) Cell Signaling Technology Cat#12619
phospho-p53 (Ser15) Cell Signaling Technology Cat#9284
ACSL4 Santa Cruz Cat#sc-271800
KEAP1 Santa Cruz Cat#sc-365626
GPX4 R&D Systems Cat#MAB5457
Tubulin Cell Signaling Technology Cat#2144
phospho-Chk2 (Thr68) Cell Signaling Technology Cat#2197
phospho-histone H2A.X (Ser139) EMD Millipore Cat#05-636
Anti-4 Hydroxynonenal (4-HNE) Abcam Cat#ab46545
Ki-67 (D2H10) Cell Signaling Technology 9027S
Cleaved Caspase-3 (Asp175) Cell Signaling Technology 9661s
Chemicals
Erastin Sigma Cat#E7781
Ferrostatin-1 Sigma Cat#SML0583
Liproxstatin-1 Sigma Cat#SML1414
N-acetyl-L-cysteine Sigma Cat#A9165
Sulfasalazine Sigma Cat#S0883
Z-VAD-fmk R&D Systems Cat#FMK001
Necrostatin-1s BioVision Cat#2263
RSL3 Selleckchem Cat#S8155
FIN56 Cayman Chemical Cat#25180
ML162 Cayman Chemical Cat#20455
CM-H2DCFDA ThermoFisher Cat#C6827
BODIPY 581/591 C11 Invitrogen Cat#D3861
Critical Commercial Assays
Cell Counting Kit-8 (CCK8) reagent Dojindo Molecular Technologies Cat#CK04
Experimental Models: Cell Lines
A549 ATCC Cat#CCL-185
H460 ATCC Cat#HTB-177
H1299 ATCC Cat#CRL-5803
H23 ATCC Cat#CRL-5800
MCF7 ATCC Cat#HTB-22
HT-1080 ATCC Cat#CCL-121
FLO-1 Dr. Steven H. Lin at MD Anderson Cancer Center
UMRC6 Dr. William G. Kaelin at Dana-Farber Cancer Institute
HEK293T ATCC Cat#CRL-11268
Experimental Models: Organisms/Strains
Mouse: athymic nude: Foxn1nu/nu The facility in the Department of Experimental Radiation Oncology at MD Anderson Cancer Center
NOD scid gamma (NSG) mice The facility in the Department of Experimental Radiation Oncology at MD Anderson Cancer Center
Sequence-Based Reagents
For primer and guide RNA sequences, please see Supplementary information, Table S2.
Software and Algorithms
GraphPad Prism 6 GraphPad Software, Inc.
FlowJo_V10 FlowJo, LLC
CompuSyn CompuSyn, Inc.
ImageJ NIH
SPSS 25.0 SPSS Inc.